𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum S100β protein as a marker of disease activity in patients with malignant melanoma

✍ Scribed by Muneeruddin Q. Mohammed; Hagosa D. Abraha; Roy A. Sherwood; Kenneth MacRae; Spyros Retsas

Book ID
111640823
Publisher
Springer US
Year
2001
Tongue
English
Weight
174 KB
Volume
18
Category
Article
ISSN
1357-0560

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rising levels of serum S100 protein prec
Rising levels of serum S100 protein precede other evidence of disease progression in patients with malignant melanoma
✍ C.S. Jury; E.J. Mcallister; R.M. Mackie 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

## Background: Several serum markers may be useful in the detection of metastatic melanoma, but none is in routine clinical use. ## Objective: To assess the validity of s100 protein as a serum marker of melanoma progression. ## Methods: Serum s100 protein levels were measured in 496 serum sampl

Clinical and prognostic relevance of ser
Clinical and prognostic relevance of serum S-100β protein in malignant melanoma
✍ Schultz; Diepgen; Von Den Driesch 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB

To assess the clinical and prognostic relevance of serum S-100 beta in malignant melanoma serum levels of S-100 beta protein were measured in 84 patients with malignant melanoma. Using a cut-off value of 0.3 microgram/L the sensitivity was 0% (none of 36) in patients with stage II, 31% (four of 13)